Fushine(SZ:300497) Xin Lang Cai Jing·2025-11-19 01:54Core Viewpoint - Fujian Pharmaceutical Co., Ltd. has experienced significant stock price increases this year, with a 120.14% rise year-to-date and a 25.93% increase in the last five trading days, indicating strong market interest and potential investment opportunities [1][2]. Financial Performance - For the period from January to September 2025, Fujian Pharmaceutical reported a revenue of 769 million yuan, a year-on-year decrease of 21.24%, and a net profit attributable to shareholders of -62.75 million yuan, a slight decrease of 1.09% [2]. - The company has cumulatively distributed 359 million yuan in dividends since its A-share listing, with no dividends paid in the last three years [3]. Stock Market Activity - As of November 19, the stock price reached 18.36 yuan per share, with a trading volume of 502 million yuan and a turnover rate of 6.20%, resulting in a total market capitalization of 9.89 billion yuan [1]. - The stock has appeared on the "Dragon and Tiger List" three times this year, with the most recent appearance on November 17, where it recorded a net buy of -40.63 million yuan [1]. Shareholder Information - As of September 30, 2025, the number of shareholders decreased by 7.87% to 20,700, while the average circulating shares per person increased by 5.59% to 21,347 shares [2].